Iridex Corp Sample Contracts

LEASE AGREEMENT
Lease Agreement • November 12th, 2003 • Iridex Corp • Electromedical & electrotherapeutic apparatus
AutoNDA by SimpleDocs
AGREEMENT ---------
Change of Control Agreement • August 12th, 2003 • Iridex Corp • Electromedical & electrotherapeutic apparatus • California
1 Exhibit 10.7 BUSINESS LOAN AGREEMENT
Business Loan Agreement • March 31st, 1998 • Iridex Corp • Electromedical & electrotherapeutic apparatus • California
LOAN AND SECURITY AGREEMENT
Loan and Security Agreement • November 3rd, 2016 • Iridex Corp • Electromedical & electrotherapeutic apparatus • Delaware

THIS LOAN AND SECURITY AGREEMENT (this “Agreement”) dated as of November 2, 2016 (the “Effective Date”) between SILICON VALLEY BANK, a California corporation (“Bank”), and IRIDEX CORPORATION, a Delaware corporation (“Borrower”), provides the terms on which Bank shall lend to Borrower and Borrower shall repay Bank. The parties agree as follows:

1,666,667 Shares IRIDEX CORPORATION Common Stock UNDERWRITING AGREEMENT
Underwriting Agreement • September 18th, 2018 • Iridex Corp • Electromedical & electrotherapeutic apparatus • New York

IRIDEX Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule I hereto (the “Underwriters”) for whom you are acting as representative (the “Representative”) an aggregate of 1,666,667 shares (the “Firm Shares”) of the common stock, par value $0.01 per share, of the Company (“Common Stock”). The Company also proposes to sell to the several Underwriters, at the option of the Underwriters, exercisable for 30 days from the date of the Prospectus (as defined below), up to an additional 250,000 shares of Common Stock (the “Option Shares”). The Firm Shares and the Option Shares are hereinafter referred to collectively as the “Shares”.

IRIDEX CORPORATION UNDERWRITING AGREEMENT 1,150,000 Shares of Common Stock
Underwriting Agreement • December 14th, 2016 • Iridex Corp • Electromedical & electrotherapeutic apparatus • New York

IRIDEX Corporation, a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to Roth Capital Partners, LLC (the “Underwriter”) an aggregate of 1,150,000 authorized but unissued shares (the “Firm Shares”) of common stock, par value $0.01 per share (the “Common Stock”), of the Company. The Company also proposes to sell to the Underwriter, upon the terms and conditions set forth in Section 4 hereof, up to an additional 172,500 shares of Common Stock (the “Option Shares”). The Firm Shares and the Option Shares are hereinafter collectively referred to as the “Shares.”

IRIDEX CORPORATION
Restricted Stock Unit Award Agreement • August 4th, 2011 • Iridex Corp • Electromedical & electrotherapeutic apparatus • California

Unless otherwise defined herein, the terms defined in the IRIDEX Corporation (the “Company”) 2008 Equity Incentive Plan (the “Plan”) will have the same defined meanings in this Restricted Stock Unit Award Agreement (the “Award Agreement”).

IRIDEX CORPORATION
Restricted Stock Award Agreement • August 4th, 2011 • Iridex Corp • Electromedical & electrotherapeutic apparatus • California

Unless otherwise defined herein, the terms defined in the IRIDEX Corporation 2008 Equity Incentive Plan (the “Plan”) will have the same defined meanings in this Restricted Stock Award Agreement (the “Award Agreement”).

Contract
Iridex Corp • April 6th, 2009 • Electromedical & electrotherapeutic apparatus • California

THIS SECURITY AND ANY SHARES ISSUED UPON THE EXERCISE OR CONVERSION OF THIS SECURITY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN COMPLIANCE WITH APPLICABLE STATE SECURITIES LAWS OR BLUE SKY LAWS.

IRIDEX CORPORATION CHANGE IN CONTROL SEVERANCE AGREEMENT
Change in Control Severance Agreement • October 28th, 2019 • Iridex Corp • Electromedical & electrotherapeutic apparatus • California

This Change in Control Severance Agreement (the “Agreement”) is made and entered into by and between Patrick Mercer (“Executive”) and IRIDEX Corporation, a Delaware corporation (the “Company”), effective as of October 25, 2019 (the “Effective Date”).

IRIDEX CORPORATION
Equity Incentive Plan • November 21st, 2008 • Iridex Corp • Electromedical & electrotherapeutic apparatus • California

Unless otherwise defined herein, the terms defined in the IRIDEX Corporation 2008 Equity Incentive Plan (the “Plan”) will have the same defined meanings in this Stock Option Award Agreement (the “Award Agreement”).

Export-Import Bank of the United States Working Capital Guarantee Program Borrower Agreement
Borrower Agreement • April 2nd, 2008 • Iridex Corp • Electromedical & electrotherapeutic apparatus

THIS BORROWER AGREEMENT (this “Agreement”) is made and entered into by the entity identified as Borrower on the signature page hereof (“Borrower”) in favor of the Export-Import Bank of the United States (“Ex-Im Bank”) and the institution identified as Lender on the signature page hereof (“Lender”).

IRIDEX CORPORATION INDEMNIFICATION AGREEMENT
Indemnification Agreement • March 15th, 2022 • Iridex Corp • Electromedical & electrotherapeutic apparatus • Delaware

This Indemnification Agreement (“Agreement”) is entered into effective as of [insert date], by and between IRIDEX Corporation, a Delaware corporation (the “Company”) and [insert name of indemnitee] (“Indemnitee”).

ASSET PURCHASE AGREEMENT
Asset Purchase Agreement • March 4th, 2021 • Iridex Corp • Electromedical & electrotherapeutic apparatus • California

This ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of March 2, 2021 (the “Agreement Date”) by and between IRIDEX Corporation, a Delaware corporation (“Acquiror”), and Topcon Medical Laser Systems, Inc., a California corporation (the “Company”, and collectively with Acquiror, the “Parties”), and, solely for the purpose of Section 11.15, Topcon America Corporation, a Delaware corporation (“Guarantor”).

JOINT FILING AGREEMENT
Joint Filing Agreement • January 8th, 2009 • Iridex Corp • Electromedical & electrotherapeutic apparatus

This Joint Filing Agreement may be signed in counterparts with the same effect as if the signature on each counterpart were upon the same instrument.

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • March 4th, 2021 • Iridex Corp • Electromedical & electrotherapeutic apparatus • California

This Registration Rights Agreement (this “Agreement”) is dated as of March 2, 2021 by and between IRIDEX Corporation, a company duly incorporated and existing under the laws of the State of Delaware (the “Company”), and Topcon America Corporation, a company duly incorporated and existing under the laws of the State of Delaware (the “Investor”).

DISTRIBUTION AGREEMENT
Distribution Agreement • March 4th, 2021 • Iridex Corp • Electromedical & electrotherapeutic apparatus • California

This Distribution Agreement (this “Agreement”) is entered into as of March 2, 2021 by and between Iridex Corporation, a Delaware corporation with its principal place of business at 1212 Terra Bella Avenue, Mountain View, California 94043, United States (“Iridex”), and Topcon Corporation, a corporation organized under the laws of Japan with its principal place of business at 75-1 Hasunuma-cho, Itabashi-ku, Tokyo, Japan, 174-8580 (“Topcon”). Iridex and Topcon may be referred to herein by name or, individually, as a “Party” and, collectively, as the “Parties”.

ASSET PURCHASE AGREEMENT dated November 30, 2006 by and among AMERICAN MEDICAL SYSTEMS, INC., LASERSCOPE and IRIDEX CORPORATION
Asset Purchase Agreement • December 6th, 2006 • Iridex Corp • Electromedical & electrotherapeutic apparatus • New York

THIS ASSET PURCHASE AGREEMENT, dated November 30, 2006 (this “Agreement”), is by and among American Medical Systems, Inc., a Delaware corporation (“Parent”), Laserscope, a California corporation and a wholly owned subsidiary of Parent (“Seller”), and Iridex Corporation, a Delaware corporation (“Purchaser”). Capitalized terms used in this Agreement have the meanings provided in, or in such other sections hereof as are cross-referenced in, Article 10.

FIRST AMENDMENT TO BUSINESS LOAN AND SECURITY AGREEMENT
Business Loan and Security Agreement • April 24th, 2007 • Iridex Corp • Electromedical & electrotherapeutic apparatus

This First Amendment (“First Amendment”) dated as of April 19, 2007, for reference purposes, is made to the BUSINESS LOAN AND SECURITY AGREEMENT (the “Domestic Agreement”) entered into as of January 16, 2007, by and between Mid-Peninsula Bank, part of Greater Bay Bank N.A. (“Bank”) and Iridex Corporation (“Borrower”), combining two credit facilities provided by Bank to Borrower, with one facility being a $6,000,000 principal amount asset-based revolving line of credit (“Line of Credit”) and the other facility being a $6,000,000 principal amount term loan (“Term Loan”).

FIRST AMENDMENT TO CREDIT AND SECURITY AGREEMENTS AND WAIVER OF DEFAULT
Credit and Security Agreements and Waiver of Default • November 7th, 2008 • Iridex Corp • Electromedical & electrotherapeutic apparatus • California

THIS FIRST AMENDMENT TO CREDIT AND SECURITY AGREEMENTS AND WAIVER OF DEFAULT (this “Amendment”), dated November 3, 2008, is entered into by and between IRIDEX CORPORATION, a Delaware corporation (“Company”), and WELLS FARGO BANK, NATIONAL ASSOCIATION (“Wells Fargo”), acting through its Wells Fargo Business Credit operating division.

AutoNDA by SimpleDocs
IRIDEX CORPORATION AGREEMENT AND RELEASE
Iridex Corporation • March 28th, 2013 • Iridex Corp • Electromedical & electrotherapeutic apparatus • California

This Separation Agreement and Release (“Agreement”) is made by and between Dr. Dominik Beck (“Employee”) and IRIDEX Corporation (the “Company”) (collectively referred to as the “Parties” or individually referred to as a “Party”) effective on the Effective Date (defined below).

FOURTH AMENDMENT TO LEASE
To Lease • March 31st, 2016 • Iridex Corp • Electromedical & electrotherapeutic apparatus

THIS FOURTH AMENDMENT TO LEASE (this “Amendment”) is dated as of January 31, 2016, and is entered into by and between Zappettini Investment Company, a California general partnership (“Lessor”), and IRIDEX Corporation (“Lessee”).

ASSET PURCHASE AGREEMENT by and between CUTERA, INC., a Delaware corporation, IRIDEX CORPORATION, a Delaware corporation, and as Escrow Agent Dated as of December 30, 2011
Asset Purchase Agreement • January 4th, 2012 • Iridex Corp • Electromedical & electrotherapeutic apparatus • California

This ASSET PURCHASE AGREEMENT (this “Agreement”) is entered into as of December 30, 2011 by and between, Cutera, Inc., a Delaware corporation (“Buyer”), IRIDEX Corporation, a Delaware corporation (the “Company”) and with respect to Article 7 hereof only, U.S. Bank National Association (the “Escrow Agent”).

SECOND AMENDMENT TO LEASE
Lease • November 20th, 2023 • Iridex Corp • Electromedical & electrotherapeutic apparatus

THIS SECOND AMENDMENT TO LEASE (this “Amendment”) is dated for reference purposes only as of August 29, 2022, and is entered into by and between ZIC 1212 Terra Bella LLC, a Delaware limited liability company (“Lessor”), and IRIDEX CORPORATION, a Delaware corporation (“Lessee”), with regard to the following facts:

AMENDMENT NO. 1 TO INVESTOR RIGHTS AGREEMENT
Investor Rights Agreement • April 6th, 2009 • Iridex Corp • Electromedical & electrotherapeutic apparatus • California

THIS AMENDMENT NO. 1 TO INVESTOR RIGHTS AGREEMENT (this “Amendment”) is made and entered into as of March 31, 2009, by and among IRIDEX Corporation, a Delaware corporation (the “Company”) and the undersigned Holders. Any capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in that certain Investor Rights Agreement, dated as of August 31, 2007 (the “Agreement”), by and among the Company and each of BlueLine Capital Partners, LP, BlueLine Capital Partners II, LP and BlueLine Capital Partners III, LP.

10700 Bren Road West Minnetonka, MN 55343 USA Phone: 952-933-4666 Fax: 952-930-6157
Iridex Corp • August 14th, 2007 • Electromedical & electrotherapeutic apparatus

This letter sets forth our mutual agreement with regard to: (a) the Product Supply Agreement, dated January 16, 2007, between Laserscope and Iridex Corporation (the “Supply Agreement”); (b) Iridex’s material, uncured breach of the Supply Agreement; and (c) the conditions under which Laserscope would agree not to exercise its right to terminate the Supply Agreement immediately.

SEPARATION AND RELEASE AGREEMENT
Separation and Release Agreement • November 13th, 2024 • Iridex Corp • Electromedical & electrotherapeutic apparatus • California

This Separation and Release Agreement (“Agreement”) is entered into by and between IRIDEX CORPORATION (defined to include its related organizations, foundations, subsidiaries, predecessors, successors, assigns, affiliates, and their respective officers, employees, ex-employees, and representatives and hereinafter referred as collectively as “IRIDEX” or the “Company”) and David I. Bruce (“Employee”). Employee and IRIDEX are referred to collectively herein as the Parties. This Agreement shall be effective as of the date the revocation period expires, if Employee has not revoked the Agreement (“Effective Date”).

IRIDEX CORPORATION STAND-ALONE STOCK OPTION AGREEMENT
Stand-Alone Stock Option Agreement • July 30th, 2009 • Iridex Corp • Electromedical & electrotherapeutic apparatus • California
THIRD AMENDMENT TO LEASE
Lease • November 20th, 2023 • Iridex Corp • Electromedical & electrotherapeutic apparatus

THIS THIRD AMENDMENT TO LEASE (this “Amendment”) is dated for reference purposes only as of September 21, 2023, and is entered into by and between ZIC 1212 Terra Bella LLC, a Delaware limited liability company (“Lessor”), and IRIDEX CORPORATION, a Delaware corporation (“Lessee”), with regard to the following facts:

SEPARATION AGREEMENT AND GENERAL RELEASE
Separation Agreement and General Release • June 26th, 2019 • Iridex Corp • Electromedical & electrotherapeutic apparatus

This Separation Agreement and General Release (hereinafter referred to as “Agreement”) is made and entered into by and between William M. Moore (hereinafter referred to as “Executive”) and Iridex Corporation (hereinafter referred to as “Iridex” or “Company”).

THIRD Amendment to Loan and security agreement
Loan and Security Agreement • March 23rd, 2021 • Iridex Corp • Electromedical & electrotherapeutic apparatus

THIS THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT (this “Amendment”) is entered into this 31st day of December, 2020, by and between SILICON VALLEY BANK, a California corporation (“Bank”), and IRIDEX CORPORATION, a Delaware corporation (“Borrower”).

IRIDEX CORPORATION EXPORT-IMPORT BANK LOAN AND SECURITY AGREEMENT
Loan and Security Agreement • January 22nd, 2007 • Iridex Corp • Electromedical & electrotherapeutic apparatus • California

This EXPORT-IMPORT BANK LOAN AND SECURITY AGREEMENT (the “Exim Agreement”) is entered into as of January 16, 2007, by and between Mid-Peninsula Bank, part of Greater Bay Bank N.A. (“Bank”) and Iridex Corporation (“Borrower”).

THIRD AMENDMENT TO LEASE
Lease • November 3rd, 2014 • Iridex Corp • Electromedical & electrotherapeutic apparatus

THIS THIRD AMENDMENT TO LEASE (this “Amendment”) is dated as of August 4, 2014, and is entered into by and between Zappettini Investment Company, a California general partnership (“Lessor”), and Iridex Corporation (“Lessee”).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!